Related references
Note: Only part of the references are listed.Lipid21: Complex Lipid Membrane Simulations with AMBER
Callum J. Dickson et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2022)
hIAPP-Amyloid-Core Derived D-Peptide Prevents hIAPP Aggregation and Destabilizes Its Protofibrils
Rituparna Roy et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2022)
Molecular Dynamics Simulations Indicate Aromaticity as a Key Factor in the Inhibition of IAPP(20-29) Aggregation
Kelsie M. King et al.
ACS CHEMICAL NEUROSCIENCE (2022)
Lipids and EGCG Affect α-Synuclein Association and Disruption of Nanodiscs
Henry M. Sanders et al.
BIOCHEMISTRY (2022)
Baicalein exhibits differential effects and mechanisms towards disruption of α-synuclein fibrils with different polymorphs
Yifei Yao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
The Membrane Interactions of Synuclein: Physiology and Pathology
Gautam Runwal et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021 (2021)
Green tea extract EGCG plays a dual role in Aβ42 protofibril disruption and membrane protection: A molecular dynamic study
Xuewei Dong et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2021)
Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis
Phuong H. Nguyen et al.
CHEMICAL REVIEWS (2021)
Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson's disease models
Jack Wuyang Jin et al.
COMMUNICATIONS BIOLOGY (2021)
Insights into the Mechanistic Perspective Effect of Insulin on the Nonamyloidogenic Component (NAC) and α-Synuclein Aggregation
Karina Abramov-Harpaz et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Ellagic Acid Inhibits α-Synuclein Aggregation at Multiple Stages and Reduces Its Cytotoxicity
Sanjay Kumar et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Membrane Binding of α-Synuclein Stimulates Expansion of SNARE-Dependent Fusion Pore
Ryan Khounlo et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Molecular mechanisms of resveratrol and EGCG in the inhibition of Aβ42 aggregation and disruption of Aβ42 protofibril: similarities and differences
Fangying Li et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2021)
Natural stereoisomeric flavonoids exhibit different disruptive effects and the mechanism of action on Aβ42 protofibril
Chendi Zhan et al.
CHEMICAL COMMUNICATIONS (2021)
Edaravone inhibits the conformational transition of amyloid-β42: insights from molecular dynamics simulations
Fufeng Liu et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Inhibitory Activity of Insulin on Aβ Aggregation Is Restricted Due to Binding Selectivity and Specificity to Polymorphic Aβ States
Michal Baram et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy
Mohammad Shahnawaz et al.
NATURE (2020)
Cryo-EM structure of full-length α-synuclein amyloid fibril with Parkinson's disease familial A53T mutation
Yunpeng Sun et al.
CELL RESEARCH (2020)
Parkinson's disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure
Kun Zhao et al.
NATURE COMMUNICATIONS (2020)
Naphthoquinone-Dopamine Hybrids Inhibit α-Synuclein Aggregation, Disrupt Preformed Fibrils, and Attenuate Aggregate-Induced Toxicity
Ashim Paul et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Epigallocatechin Gallate Destabilizes α-Synuclein Fibril by Disrupting the E46-K80 Salt-Bridge and Inter-protofibril Interface
Yifei Yao et al.
ACS CHEMICAL NEUROSCIENCE (2020)
α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis
Surabhi Mehra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)
Dihydromyricetin Inhibits α-Synuclein Aggregation, Disrupts Preformed Fibrils, and Protects Neuronal Cells in Culture against Amyloid-Induced Cytotoxicity
Longgang Jia et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)
Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes
Sarah H. Shahmoradian et al.
NATURE NEUROSCIENCE (2019)
Fibrils of α-Synuclein Abolish the Affinity of Cu2+-Binding Site to His50 and Induce Hopping of Cu2+ Ions in the Termini
Daniel N. y Bloch et al.
INORGANIC CHEMISTRY (2019)
Brazilin Inhibits α-Synuclein Fibrillogenesis, Disrupts Mature Fibrils, and Protects against Amyloid-Induced Cytotoxicity
Fufeng Liu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)
Amphiphilic surface chemistry of fullerenols is necessary for inhibiting the amyloid aggregation of alpha-synuclein NACore
Yunxiang Sun et al.
NANOSCALE (2019)
Nanoscale inhibition of polymorphic and ambidextrous IAPP amyloid aggregation with small molecules
Aleksandr Kakinen et al.
NANO RESEARCH (2018)
Cryo-EM structure of alpha-synuclein fibrils
Ricardo Guerrero-Ferreira et al.
ELIFE (2018)
Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
Jessika C. Bridi et al.
FRONTIERS IN NEUROSCIENCE (2018)
Amyloid fibril structure of α-synuclein determined by cryoelectron microscopy
Yaowang Li et al.
CELL RESEARCH (2018)
Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons
Jordi Pujols et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel
Binsen Li et al.
NATURE COMMUNICATIONS (2018)
Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers
Giuliana Fusco et al.
SCIENCE (2017)
(-)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of alpha-synuclein, and protects PC12 cells against alpha-synuclein-induced toxicity
Juan Zhao et al.
RSC ADVANCES (2017)
The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease
Celine Galvagnion
JOURNAL OF PARKINSONS DISEASE (2017)
Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors
Narendra Nath Jha et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Protein Ensembles: How Does Nature Harness Thermodynamic Fluctuations for Life? The Diverse Functional Roles of Conformational Ensembles in the Cell
Guanghong Wei et al.
CHEMICAL REVIEWS (2016)
The role of cholesterol in membrane fusion
Sung-Tae Yang et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2016)
Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein
Marcus D. Tuttle et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson's Disease
Yan Xu et al.
NEUROCHEMICAL RESEARCH (2016)
Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein
Marcus D. Tuttle et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation
Celine Galvagnion et al.
NATURE CHEMICAL BIOLOGY (2015)
The Synaptic Function of α-Synuclein
Jacqueline Burre
JOURNAL OF PARKINSONS DISEASE (2015)
How Epigallocatechin Gallate Can Inhibit α-Synuclein Oligomer Toxicity in Vitro
Nikolai Lorenzen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour
Giuliana Fusco et al.
NATURE COMMUNICATIONS (2014)
Molecular Mechanism of the Inhibition of EGCG on the Alzheimer Aβ1-42 Dimer
Tong Zhang et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2013)
Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid Fibrils
Fernando L. Palhano et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Nunilo Cremades et al.
CELL (2012)
Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications
Brahma N. Singh et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Abnormal Neurites Containing C-Terminally Truncated α-Synuclein Are Present in Alzheimer's Disease without Conventional Lewy Body Pathology
Karen A. Lewis et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Modulation of Alpha-Synuclein Aggregation by Dopamine Analogs
Diane Latawiec et al.
PLOS ONE (2010)
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Jan Bieschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Improved side-chain torsion potentials for the Amber ff99SB protein force field
Kresten Lindorff-Larsen et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Software news and updates - CHARNIM-GUI: A web-based grraphical user interface for CHARMM
Sunhwan Jo et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2008)
Site-specific interactions of Cu(II) with α and β-synuclein:: Bridging the molecular gap between metal binding and aggregation
Andres Binolfi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Design of an N-methylated peptide inhibitor of α-synuclein aggregation guided by solid-state NMR
Jillian Madine et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Sequence determinants for amyloid fibrillogenesis of human α-synuclein
Shahin Zibaee et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Small molecule inhibitors of α-synuclein filament assembly
Masami Masuda et al.
BIOCHEMISTRY (2006)
The Amber biomolecular simulation programs
DA Case et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
α-Synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast
C Dixon et al.
GENETICS (2005)
Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease
J Li et al.
FASEB JOURNAL (2004)
The association of α-synuclein with membranes affects bilayer structure, stability, and fibril formation
M Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
KA Conway et al.
SCIENCE (2001)
Share Paper
